<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04338503</url>
  </required_header>
  <id_info>
    <org_study_id>CFT-37215-STH-01</org_study_id>
    <nct_id>NCT04338503</nct_id>
  </id_info>
  <brief_title>Balancing Ventricular Function in Heart Failure Patients</brief_title>
  <official_title>Balancing Ventricular Function Using Partial Inferior Vena Cava Occlusion to Reduce Pulmonary Pressures in Heart Failure Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cardioflow Technologies, LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Saint Thomas Hospital, Panama</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Cardioflow Technologies, LLC</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the current study is to determine if partial balloon occlusion of the inferior
      vena cava can optimize cardiac pre-load and subsequently pulmonary pressures and cardiac
      output as a novel method to unload pulmonary edema and other symptoms of decompensated
      congestive heart failure. All products in this study are FDA approved and adhere to the
      specifications of the intended use.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2020</start_date>
  <completion_date type="Anticipated">August 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in pulmonary arterial pressures</measure>
    <time_frame>During partial balloon occlusion</time_frame>
    <description>Change in the measured mean pulmonary arterial pressure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in cardiac output</measure>
    <time_frame>During partial balloon occlusion</time_frame>
    <description>Change in cardiac output measured in liters per minute</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>HF patients</arm_group_label>
    <description>Decompensated heart failure patients undergoing right heart catheterization.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Partial IVC occlusion</intervention_name>
    <description>Partial balloon occlusion of the inferior vena cava.</description>
    <arm_group_label>HF patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Decompensated congestive heart failure patients referred for right heart catheterization.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subjects scheduled to undergo a right heart catheterization at Saint Thomas Hospital.

          2. New York Heart Association (NYHA) II or III.

          3. Subjects must be last least 18 years of age.

          4. A left ventricular ejection fraction &gt;= 20%.

          5. Pulmonary artery occlusion pressure, or pulmonary wedge pressure &gt;20 mmHg.

        Exclusion Criteria:

          1. Subjects without sinus rhythm.

          2. Evidence of right heart failure.

          3. Patients with primary pulmonary hypertension

          4. Pulmonary wedge pressure &lt;15mmHg.

          5. Significant lung disease, such as prior diagnosis of COPD.

          6. Resting or dynamic outflow tract gradient

          7. Patients with left bundle branch block
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Daniel W Kaiser, MD</last_name>
    <phone>6154152586</phone>
    <email>dan@cardioflowtech.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Saint Thomas Heart</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37205</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Lynn Peterson</last_name>
      <phone>615-222-4504</phone>
      <email>speterso@ascension.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 5, 2020</study_first_submitted>
  <study_first_submitted_qc>April 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 8, 2020</study_first_posted>
  <last_update_submitted>April 5, 2020</last_update_submitted>
  <last_update_submitted_qc>April 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pulmonary edema, preload</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

